Viewing Study NCT06511999



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06511999
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-15

Brief Title: Continuous Jugular Venous Oxygen Saturation SjO2 Measurement After Cardiac Arrest
Sponsor: None
Organization: None

Study Overview

Official Title: Feasibility and Validation of Continuous Measurement of Jugular Venous Oxygen Saturation in Comatose Patients After Cardiac Arrest
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients successfully resuscitated from sudden cardiac arrest are often comatose having suffered a period of low blood flow and oxygen delivery to the brain They are also at risk of suffering further brain injury during the immediate period after resuscitation in which the brains normal regulatory functions are impaired To diagnose and treat secondary brain injury in comatose patients after cardiac arrest doctors use a variety of neurological monitoring techniques One of these methods involves measuring the oxygen saturation of blood going into and out of the brain to determine whether the brain is receiving and utilizing oxygen in an optimal manner The oxygen saturation of blood exiting the brain is called the jugular venous oxygen saturation SjO2 It is measured by inserting a catheter into the jugular vein in the neck and sampling blood as it exits the skull The blood sample is sent to the hospital laboratory and the oxygen saturation is measured on a blood gas machine This method of SjO2 measurement has limitations particularly that blood must be taken out of the patient and sent to the lab for analysis which can only be done feasibly every few hours Special catheters exist that can measure the oxygen saturation of blood passing by the tip of the catheter inside the patient on a second-by-second basis without needing to withdraw blood and send it to the laboratory With such rapidly available data doctors may be able to better diagnose and treat brain oxygen abnormalities in post cardiac arrest patients

In this study the investigators plan to determine the accuracy of an existing Food and Drug Administration FDA-cleared catheter capable of continuous indwelling measurement of venous blood oxygen saturation for SjO2 monitoring in comatose patients early after cardiac arrest The SjO2 measurements from the study catheter will be compared with standard SjO2 measurements made by withdrawing blood and analyzing it in the laboratory to determine if the new catheter is accurate The investigators will also collect blood samples using the study catheter to measure levels of specific proteins that indicate damage to brain tissue The study will enroll 25 participants admitted to the intensive care unit at one hospital cared for by a group of doctors that specialize in the neurological care of patients after cardiac arrest The investigators hypothesize that the study catheter will accurately measure SjO2 compared to the standard laboratory method
Detailed Description: Patients who achieve return of spontaneous circulation ROSC after sudden cardiac arrest and remain comatose are at high risk of secondary brain injury that may prevent or worsen the quality of neurological recovery Current treatments that attempt to mitigate the extent of secondary brain injury include targeted temperature management TTM maintenance of adequate blood pressure and gas exchange oxygen and carbon dioxide and antiepileptic treatment of seizures and other hyperexcitable patterns detected on electroencephalographic EEG monitoring Multiple recent large-scale clinical trials comparing different magnitudes of such therapies mild hypothermia vs controlled normothermia or fever prevention aggressive antiseizure treatment of rhythmicperiodic patterns vs no treatment or resuscitation targets oxygen carbon dioxide and blood pressure goals did not detect improvement in neurologic outcome with the hypothesized superior interventions Research from the investigators and others suggests that between-patient heterogeneity in patterns and severity of hypoxic-ischemic brain injury HIBI after cardiac arrest may explain the repeated failure to find a population-level benefit of any particular one-size-fits-all therapy individual patients exhibit differing pathophysiology and may respond best to different neuroprotective interventions

To tailor potential neuroprotective treatments to individual patients doctors must be able to detect and characterize neurological pathophysiology and treatment responsiveness in real time This requires use of one or more prospective neuromonitoring modalities including measurement of jugular venous oxygen saturation SjO2 Measurement of SjO2 involves inserting a catheter retrograde into the internal jugular vein and determining the oxygen saturation of blood just after it leaves the skull By comparing the SjO2 with the saturation of arterial blood SaO2 entering the brain measured from a large artery the percentage of oxygen extracted by the brain can be determined SaO2 - SjO2 This is akin to measuring central venous oxygen saturation ScvO2 in various types of circulatory shock Measurement of SjO2 early after cardiac arrest provides information on the balance between brain-specific oxygen supply utilization and demand Identification of abnormal brain oxygen balance during this time period in which secondary brain injury is most likely to occur can trigger and guide potentially corrective therapies

The Post Cardiac Arrest Service PCAS at UPMC Presbyterian uses SjO2 monitoring in comatose patients after cardiac arrest as part of routine prognostic and therapeutic purposes for the first 72 hours of hospitalization Prior research has shown a significant association between elevated mean SjO2 75 during the early post-arrest period and poor outcomes It is hypothesized that this represents either poor brain oxygen extraction resulting from abnormalities in diffusion through peri-neuronal tissue or impaired mitochondrial oxygen uptake and utilization leading to elevated oxygen saturationcontent in venous blood leaving the injured brain Preliminary case series by the investigators and Hoiland et al have shown that some patients with elevated SjO2 exhibit a decrease in SjO2 and concomitant increase in brain oxygen utilization after treatment with hypertonic saline HTS suggesting that abnormal oxygen diffusion due to perivascular edema plays some part in the pathophysiology of post-arrest HIBI

The ability to detect and act upon abnormal brain oxygen balance particularly oxygenation changes that may result from potential neuroprotective interventions is limited by current SjO2 measurement technology Presently SjO2 is measured by withdrawing blood from a single lumen 3-4 French 10-15 cm-long catheter on an intermittent basis every 4-6 hours and calculating venous oxygen saturation from the blood sample on a blood gas analyzer in the hospital laboratory As a result SjO2 data granularity is limited by the practical frequency of blood draws and lab result turn-around time However vascular catheter technology allowing for continuous in-dwelling measurement of venous blood oxygen saturation via spectrophotometry exists and is routinely used to monitor central venous oxygen saturation ScvO2 and mixed venous oxygen saturation SvO2 in patients with cardiogenic shock Specifically an FDA-cleared continuous venous oximetry-enabled peripherally inserted central catheter PICC TriOx PICC ICU Medical San Clemente CA dual lumen 5 French 45 cm is currently used for measurement of ScVO2 in patients with cardiogenic shockpost cardiac-surgery This catheter also allows for intermittent blood sampling The investigators seek to translate this existing continuous venous oximetry technology for use in the measurement of SjO2 To do so the investigators plan to perform a prospective observational case series study to determine the feasibility and accuracy of continuous measurement of SjO2 with the TriOx PICC compared to the standard technique of measurement via blood sampling analysis on a laboratory blood gas machine in comatose participants at risk of secondary brain injury after cardiac arrest The investigators also plan to demonstrate the feasibility of obtaining and storing jugular blood samples using the continuous SjO2 catheter for future biomarker analysis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None